Microsoft Corporation (MSFT) Is Coming Under Some Selling Pressure This Morning. The Stock Is Trading

This story gets to the heart of one of the biggest problems with Obamacare: the difference between health insurance and health care.

from Forbes (emphasis mine):

For someone in the middle of a cancer treatment, or someone with a chronic condition, this can be extraordinarily...

This is truly tragic. It’s time to count 87,000 Blue Cross and Blue Shield of Alabama customers among the millions of Americans who have lost their health insurance because of Obamacare.

From AL.com:

Blue Cross and Blue Shield of Alabama recently notified about 87,000 policy holders in the...

#NYSE : $UA · Under Armour, Inc.  

40.4% gain 3-months : 56.35 -> 79.11   0.1% gain 2-weeks   : 79.0 -> 79.11

1,154,500 median volume (3 months) …max: 5,778,100 …avg: 1,260,723 …min: 475,400

70.1%  daily positive gains (47/67 days)

Goldman Sachs Upgrades Lazard Ltd to a "Conviction Buy"

We talked about Lazard (not to be confused with Lazard Capital Markets) a couple weeks ago after they released a Levelized Cost of Energy Analysis. If you did not read that article Lazard is a global financial advisory firm founded in 1848. They operate all over the world and specializes in giving advice on mergers and acquisitions, strategic matter as well as restructuring and capital structure. Goldman Sachs on Monday upgraded Lazard to "Conviction Buy" from "Neutral." They also raised their price target to $45 from the previous $37. In a statement Goldman Sachs analyst Alexander Blostein said, “We believe the Street underestimates LAZ’s margin improvement opportunity in 2014 given strengthening revenue backdrop in both the Advisory and Asset Mgmt. businesses, and cost cut realization... “With modest revenue growth assumptions, we believe LAZ should achieve its 25% operating margin target, leaving us about 10% above consensus for the next two years. Furthermore, in our view, the firm’s significant cash flow generation (13% FCF yield) creates opportunities for corporate debt reduction starting in 2015, as well as dividend growth over time. Longer-term, we believe LAZ provides the most upside potential to an improving global M&A cycle mainly due to its European presence – currently the largest drag on M&A volumes.” For more information on Lazard's successes, the New York Times released an article here

http://aclassasset.blogspot.com/2013/10/goldman-sachs-upgrades-lazard-ltd-to.html

Lloyd a buy after de-nationalization

Kenya’s drugs regulatory authority the Pharmacy and Poisons Board of Kenya (PPB) and TradeMark East Africa (TMEA) have launched a new e-portal that will enable the pharmaceutical industry’s stakeholders to access trade and drug retention services online.

The system will enable importers of medical drugs to make their orders online and make electronic payments as well. The government expects the new system to boost the pharmaceutical sector by easing access to services provided.

The Kenyan middle class is an emerging demographic in need of hospitality and food services. Hellofood is a business venture originating out of Berlin’s Rocket Internet e-business incubator. The business has grown to several countries including Ghana, Senegal and Morocco.

“You need to...

Last night, JP Morgan was about to roll out a Q&A with #AskJPM and things went wrong.. very wrong.

More highlights here: trib.in/1bqIdEN